This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ucb Pharma Gmbh. Active years: 2014-2015.
Company Filing History:
Years Active: 2014-2015
Title: Oliver Ackaert: Innovator in Pharmaceutical Compositions
Introduction
Oliver Ackaert is a notable inventor based in Essen, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the delivery of medications for central nervous system disorders.
Latest Patents
Ackaert holds 2 patents related to pharmaceutical compositions comprising rotigotine salts, specifically designed for iontophoresis. His inventions focus on new salts of 6-(propyl-(2-thiophen-2-ylethyl)amino)tetralin-1-ol (rotigotine) and their application as medicaments for treating conditions such as Parkinson's Disease, Restless Legs Syndrome (RLS), fibromyalgia, and depression. The formulations he developed are characterized by their good to excellent solubility in aqueous solutions, which facilitates enhanced iontophoretic delivery to target tissues.
Career Highlights
Oliver Ackaert is currently associated with Ucb Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work is pivotal in advancing treatment options for patients suffering from various CNS disorders.
Collaborations
Ackaert collaborates with esteemed colleagues such as Johanna Aaltje Bouwstra and Jacob Eikelenboom, contributing to a dynamic research environment that fosters innovation.
Conclusion
Oliver Ackaert's contributions to pharmaceutical compositions demonstrate his commitment to improving treatment methods for CNS disorders. His innovative work continues to impact the field positively.